Literature DB >> 4566623

Antibodies to TRIC agents in tears and serum of naturally infected humans.

L Hanna, E Jawetz, O C Briones, H Keshishyan, I Hoshiwara, H B Ostler, C R Dawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4566623     DOI： 10.1093/infdis/127.1.95

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Trachoma: an overview.

Authors:  K F Tabbara
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

2.  Comparison of four serological methods for detecting antibodies to Chlamydia trachomatis.

Authors:  A Rai; V M Mahajan
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

Review 3.  Spectrum of human chlamydial infections.

Authors: 
Journal:  West J Med       Date:  1981-09

Review 4.  The rôle of Chlamydia trachomatis in genital-tract and associated diseases.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1980-03       Impact factor: 3.411

5.  Chlamydia keratoconjunctivitis determination of Chlamydia trachomatis specific secretory immunoglobulin A in tears by enzyme immunoassay.

Authors:  N J Buisman; J M Ossewaarde; M Rieffe; A M van Loon; J S Stilma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Human cell-mediated immune responses to chlamydial antigens.

Authors:  L Hanna; L Schmidt; M Sharp; D P Stites; E Jawetz
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Failure of serology in diagnosing chlamydial infections of the female genital tract.

Authors:  J Schachter; L Cles; R Ray; P A Hines
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

8.  Antichlamydial antibody in tears and sera, and serotypes of Chlamydia trachomatis isolated from schoolchildren in Southern Tunisia.

Authors:  J D Treharne; R S Dwyer; S Darougar; B R Jones; T Daghfous
Journal:  Br J Ophthalmol       Date:  1978-08       Impact factor: 4.638
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.